Optimize Your Clinical Trial Supply Chain

Improve the efficiency of your clinical trials with our comparator drug sourcing and clinical trial supply chain solutions.

 

“Focus on your clinical trials, not sourcing.”

Draw on the strength of our relationships with pharmaceutical manufacturers worldwide to give your clinical trial team access to authentic, commercially available drugs, as well as confidential, strategic advice that can help avoid costly delays.

How we help you:

  • Leveraging our relationships with Generic manufacturers to get your trial guaranteed NIMP supply with access to full documentation.
  • Working with our manufacturer partners to build your needs into supply forecasts- gaining best expiry dates, documentation, and shortest supply chain.
  • Ability to leverage our Investigational Pharmacies for Direct to Patient supply.
  • Utilizing the full McKesson infrastructure to provide products from across North America and Europe.

You’ll benefit from:

  • Global capabilities that enable sourcing from the US, Canada and across Europe
  • World-class supply chain operations that are consistent, timely, and secure
  • Market-leading access to branded, generic, specialty, plasma and biologic drugs, direct from manufacturers
  • Dedicated customer service and operations teams with an ability to source based on custom requirements
  • Supply planning and forecasting for large, complex, and multi-phase trials

NABP Drug Distributor Accreditation

Drug DistributorThe NABP Drug Distributor Accreditation, formerly VAWD, is for facilities engaged in the act of wholesale drug distribution. To become accredited, facilities must undergo a criteria compliance review, which includes: a rigorous review of their operating policies and procedures; licensure verification; a survey of a facility’s operations; and screening through the NABP Clearinghouse.

The NABP Drug Distributor Accreditation plays a pivotal role in preventing counterfeit drugs from entering the United States (US) drug supply: it helps protect the public from drugs that have been contaminated, diverted, or counterfeited. The US supply of prescription drugs is produced and delivered to patients via a complex distribution path, and the accreditation helps ensure that the wholesale distribution facility operates legitimately, is licensed in good standing, and is employing security and best practices for safely distributing comparator drugs directly from manufacturers to our customer.

********* Embedded Contact Object*******
  • Contact Us

    Learn more about McKesson solutions for biopharma and life sciences companies.

    Get in Touch

top